Polyacrylic acid nanoplatforms: Antimicrobial, tissue engineering, and cancer theranostic applications

H Arkaban, M Barani, MR Akbarizadeh… - Polymers, 2022 - mdpi.com
Polyacrylic acid (PAA) is a non-toxic, biocompatible, and biodegradable polymer that gained
lots of interest in recent years. PAA nano-derivatives can be obtained by chemical …

Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders

S Mandal, P Vishvakarma… - Current Drug Research …, 2024 - benthamdirect.com
According to the current information, using nano gels in the eyes have therapeutic benefits.
Industry growth in the pharmaceutical and healthcare sectors has been filled by …

Anti‐oxidative and anti‐inflammatory micelles: break the dry eye vicious cycle

S Li, Z Lu, Y Huang, Y Wang, Q Jin, X Shentu… - Advanced …, 2022 - Wiley Online Library
Dry eye disease (DED) impacts≈ 30% of the world's population and causes serious ocular
discomfort and even visual impairment. Inflammation is one core cause of the DED vicious …

Polyacrylic acid-based drug delivery systems: A comprehensive review on the state-of-art

G Dalei, S Das - Journal of Drug Delivery Science and Technology, 2022 - Elsevier
Polyacrylic acid (PAA)-based drug carrier systems have garnered much significance
towards the delivery of various therapeutic agents via different administration routes for the …

Advances in nanogels for topical drug delivery in ocular diseases

Y Wu, Q Tao, J Xie, L Lu, X Xie, Y Zhang, Y Jin - Gels, 2023 - mdpi.com
Nanotechnology has accelerated the development of the pharmaceutical and medical
technology fields, and nanogels for ocular applications have proven to be a promising …

γ-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis

G Fang, Q Wang, X Yang, Y Qian, G Zhang… - Carbohydrate polymers, 2022 - Elsevier
Anterior uveitis is a sight-threatening inflammation inside the eyes. Conventional eye drops
for anti-inflammatory therapy need to be administered frequently owing to the rapid …

Why chitosan could be apt candidate for glaucoma drug delivery-An overview

BN Kumara, R Shambhu, KS Prasad - International Journal of Biological …, 2021 - Elsevier
Most of the people in the world are affected by glaucoma, which leads to irreversible
blindness. Several patient friendly treatments are available, nevertheless medications lack …

Recent advances in hydrogels for the diagnosis and treatment of dry eye disease

Q Li, Y Cao, P Wang - Gels, 2022 - mdpi.com
Dry eye disease (DED) is the most common clinical ocular surface disease. Given its
multifactorial etiology, no consensus has been reached on the diagnosis criteria for dry eye …

Biomaterials for dry eye disease treatment: Current overview and future perspectives

M Thacker, V Singh, S Basu, S Singh - Experimental Eye Research, 2023 - Elsevier
Dry eye disease (DED) is an emerging health problem affecting millions of individuals every
year. The current treatments for DED include lubricating eye drops and anti-inflammatory …

[HTML][HTML] Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization

Y Xiang, Z Qiu, Y Ding, M Du, N Gao, H Cao… - Journal of Controlled …, 2024 - Elsevier
Dexamethasone (DEX) has been demonstrated to inhibit the inflammatory corneal
neovascularization (CNV). However, the therapeutic efficacy of DEX is limited by the poor …